Guang Ji Selected Research

salvia-nelumbinis naturalis extract

7/2021	Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway.
8/2014	Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang Ji Research Topics

Disease

55	Non-alcoholic Fatty Liver Disease 04/2024 - 02/2008
40	Neoplasms (Cancer) 03/2024 - 05/2012
22	Inflammation (Inflammations) 03/2024 - 05/2007
18	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 04/2014
18	Alcoholic Fatty Liver 01/2024 - 06/2005
15	Obesity 01/2022 - 01/2012
14	Body Weight (Weight, Body) 12/2023 - 10/2011
12	Insulin Resistance 11/2023 - 01/2010
11	Fatty Liver 01/2022 - 01/2004
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2023 - 01/2015
9	Carcinogenesis 11/2022 - 11/2017
8	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2013
8	Liver Cirrhosis (Hepatic Cirrhosis) 09/2018 - 07/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 05/2012
6	Fibrosis (Cirrhosis) 01/2024 - 07/2003
6	Neoplasm Metastasis (Metastasis) 07/2023 - 07/2010
6	Infections 01/2023 - 01/2017
6	Breast Neoplasms (Breast Cancer) 11/2021 - 07/2010
6	Liver Diseases (Liver Disease) 12/2020 - 01/2010
6	Hyperglycemia 12/2020 - 01/2013
5	Fatigue 04/2024 - 06/2005
5	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 07/2003
5	Adenoma (Adenomas) 01/2023 - 06/2020
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2013
4	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 11/2014
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
4	Carcinoma (Carcinomatosis) 05/2022 - 11/2013
4	Dysbiosis 01/2022 - 01/2021
4	Chronic Hepatitis B 01/2017 - 10/2009
4	Anorexia 02/2008 - 07/2003
3	Stomach Neoplasms (Stomach Cancer) 03/2024 - 03/2011
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2023 - 01/2020
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023 - 01/2009
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2015
3	Hypertension (High Blood Pressure) 03/2021 - 01/2015
3	Muscular Diseases (Myopathy) 11/2020 - 05/2018
3	Poliomyelitis (Polio) 01/2020 - 06/2011
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 04/2024 - 10/2019
2	Disease Progression 01/2024 - 03/2020
2	Dyspepsia (Indigestion) 12/2023 - 05/2011
2	Chronic Disease (Chronic Diseases) 01/2023 - 01/2022
2	Ulcerative Colitis 01/2023 - 01/2020
2	Weight Loss (Weight Reduction) 11/2022 - 07/2015
2	Dysferlinopathy 11/2022 - 05/2018
2	Muscular Dystrophies (Muscular Dystrophy) 11/2022 - 05/2018
2	Overweight 10/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

27	LipidsIBA 04/2024 - 07/2003
16	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2011
16	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2004
15	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 10/2011
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2008
11	Bile Acids and Salts (Bile Acids)IBA 10/2023 - 01/2016
10	Therapeutic UsesIBA 01/2023 - 01/2004
10	CytokinesIBA 01/2023 - 07/2003
9	Blood Glucose (Blood Sugar)IBA 12/2023 - 10/2011
8	EnzymesIBA 11/2023 - 09/2008
8	qinggan huoxueIBA 01/2023 - 07/2003
8	RNA (Ribonucleic Acid)IBA 11/2022 - 10/2017
8	CholesterolIBA 01/2022 - 09/2008
7	Methionine (L-Methionine)FDA Link 04/2024 - 11/2014
7	Circular RNAIBA 11/2022 - 07/2019
6	Choline (Choline Chloride)IBA 04/2024 - 11/2014
6	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2004
6	CateninsIBA 01/2022 - 09/2015
6	BerberineIBA 01/2021 - 10/2011
6	Insulin (Novolin)FDA Link 09/2017 - 10/2011
5	LeptinIBA 01/2016 - 09/2008
4	kaempferolIBA 03/2024 - 11/2020
4	jiangzhiIBA 05/2022 - 09/2011
4	Transaminases (Aminotransferases)IBA 01/2022 - 11/2014
4	MicroRNAs (MicroRNA)IBA 09/2021 - 01/2018
4	AntioxidantsIBA 03/2021 - 12/2011
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2020 - 01/2004
4	puerarinIBA 09/2018 - 07/2006
3	Sijunzi decoctionIBA 04/2024 - 10/2019
3	N-methyladenosineIBA 01/2024 - 07/2020
3	Lipoproteins (Lipoprotein)IBA 11/2023 - 01/2015
3	Amino Acids FDA Link 05/2022 - 07/2017
3	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2018
3	Liver X ReceptorsIBA 01/2021 - 09/2011
3	oxidized low density lipoproteinIBA 07/2020 - 01/2013
3	LDL CholesterolIBA 01/2020 - 01/2012
3	HDL CholesterolIBA 12/2018 - 10/2012
3	Messenger RNA (mRNA)IBA 01/2018 - 09/2008
3	LipopolysaccharidesIBA 01/2017 - 05/2012
3	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2012 - 07/2006
2	6-methyladenineIBA 11/2023 - 01/2022
2	ChemokinesIBA 07/2023 - 08/2022
2	GlucokinaseIBA 01/2023 - 01/2019
2	ling-gui-zhu-gan decoctionIBA 01/2023 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2018
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2023 - 01/2020
2	DysferlinIBA 11/2022 - 05/2018
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 12/2016
2	MethyltransferasesIBA 09/2022 - 01/2022

Therapy/Procedure

29	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 05/2009
25	Therapeutics 05/2024 - 02/2011
6	Aftercare (After-Treatment) 04/2024 - 01/2004
5	Drug Therapy (Chemotherapy) 04/2024 - 01/2017
4	Immunotherapy 01/2022 - 01/2021